New approach methodologies to enhance human health risk assessment of immunotoxic properties of chemicals - a PARC (Partnership for the Assessment of Risk from Chemicals) project.

Autor: Snapkow I; Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway., Smith NM; Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway., Arnesdotter E; Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg., Beekmann K; Wageningen Food Safety Research (WFSR), Part of Wageningen University and Research, Wageningen, Netherlands., Blanc EB; T3S, INSERM UMR-S 1124, Université Paris Cité, Paris, France., Braeuning A; Department of Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany., Corsini E; Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Université degli Studi di Milano, Milan, Italy., Sollner Dolenc M; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia., Duivenvoorde LPM; Wageningen Food Safety Research (WFSR), Part of Wageningen University and Research, Wageningen, Netherlands., Sundstøl Eriksen G; Norwegian Veterinary Institute, Oslo, Norway., Franko N; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia., Galbiati V; Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Université degli Studi di Milano, Milan, Italy., Gostner JM; Biochemical Immunotoxicology Group, Institute of Medical Biochemistry, Medical University of Innsbruck, Innsbruck, Austria., Grova N; Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg., Gutleb AC; Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg., Hargitai R; Unit of Radiation Medicine, Department of Radiobiology and Radiohygiene, National Centre for Public Health and Pharmacy, Budapest, Hungary., Janssen AWF; Wageningen Food Safety Research (WFSR), Part of Wageningen University and Research, Wageningen, Netherlands., Krapf SA; Section for Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway., Lindeman B; Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway., Lumniczky K; Unit of Radiation Medicine, Department of Radiobiology and Radiohygiene, National Centre for Public Health and Pharmacy, Budapest, Hungary., Maddalon A; Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Université degli Studi di Milano, Milan, Italy., Mollerup S; Section for Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway., Parráková L; Biochemical Immunotoxicology Group, Institute of Medical Biochemistry, Medical University of Innsbruck, Innsbruck, Austria., Pierzchalski A; Helmholtz Centre for Environmental Research, Leipzig, Germany., Pieters RHH; Innovative Testing in Life Sciences and Chemistry, Research Center for Healthy and Sustainable Living, University of Applied Sciences, Utrecht, Netherlands.; IRAS-Toxicology, Population Health Sciences, Faculty of Veterinary Sciences, Utrecht University, Utrecht, Netherlands., Silva MJ; Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal., Solhaug A; Norwegian Veterinary Institute, Oslo, Norway., Staal YCM; Centre for Health Protection, National Institute of Public Health and the Environment, Bilthoven, Netherlands., Straumfors A; Section for Occupational Toxicology, National Institute of Occupational Health, Oslo, Norway., Szatmári T; Unit of Radiation Medicine, Department of Radiobiology and Radiohygiene, National Centre for Public Health and Pharmacy, Budapest, Hungary., Turner JD; Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg., Vandebriel RJ; Centre for Health Protection, National Institute of Public Health and the Environment, Bilthoven, Netherlands., Zenclussen AC; Helmholtz Centre for Environmental Research, Leipzig, Germany., Barouki R; T3S, INSERM UMR-S 1124, Université Paris Cité, Paris, France.

Publikováno v: Frontiers in toxicology [Front Toxicol] 2024 Apr 09; Vol. 6, pp. 1339104. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).

Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis

Autor: Frizzell, C. ^{a, 1}, Ndossi, D. ^{b, c, 1}, Verhaegen, S. ^b, Dahl, E. ^b, Eriksen, G. ^d, Sørlie, M. ^e, Ropstad, E. ^b, Muller, M. ^f, Elliott, C.T. ^a, Connolly, L. ^{a, ⁎}

Publikováno v: In Toxicology Letters 10 October 2011 206(2):210-217

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic Study.

Autor: Kvaslerud AB; Department of Cardiology, Rikshospitalet, Oslo University Hospital, Norway (A.B.K., E.G., G.E., A.K.A., L.G., K.B.).; KG Jebsen Center for Cardiac Research, Center for Heart Failure Research (A.B.K., L.G., K.B.), University of Oslo, Norway.; Faculty of Medicine (A.B.K., L.G., K.B.), University of Oslo, Norway., Gude E; Department of Cardiology, Rikshospitalet, Oslo University Hospital, Norway (A.B.K., E.G., G.E., A.K.A., L.G., K.B.)., Eriksen G; Department of Cardiology, Rikshospitalet, Oslo University Hospital, Norway (A.B.K., E.G., G.E., A.K.A., L.G., K.B.)., Andreassen AK; Department of Cardiology, Rikshospitalet, Oslo University Hospital, Norway (A.B.K., E.G., G.E., A.K.A., L.G., K.B.)., Gullestad L; Department of Cardiology, Rikshospitalet, Oslo University Hospital, Norway (A.B.K., E.G., G.E., A.K.A., L.G., K.B.).; KG Jebsen Center for Cardiac Research, Center for Heart Failure Research (A.B.K., L.G., K.B.), University of Oslo, Norway.; Faculty of Medicine (A.B.K., L.G., K.B.), University of Oslo, Norway., Broch K; Department of Cardiology, Rikshospitalet, Oslo University Hospital, Norway (A.B.K., E.G., G.E., A.K.A., L.G., K.B.).; KG Jebsen Center for Cardiac Research, Center for Heart Failure Research (A.B.K., L.G., K.B.), University of Oslo, Norway.; Faculty of Medicine (A.B.K., L.G., K.B.), University of Oslo, Norway.

Publikováno v: Circulation. Heart failure [Circ Heart Fail] 2022 Feb; Vol. 15 (2), pp. e009253. Date of Electronic Publication: 2022 Feb 09.